{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:25:15Z","timestamp":1781072715699,"version":"3.54.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Newcastle Hospital Charity"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Medications contribute 25% of NHS England\u2019s carbon emissions, with the pharmaceutical sector significantly impacting its carbon footprint (CF). Limited research exists on the environmental impact of different formulations of the same drug. This project evaluated morphine, a potent opioid for moderate to severe pain, focusing on immediate-release (IR) formulations: oral tablets, oral solutions, and injections. Oral morphine solution is commonly the first line for acute or breakthrough pain. This study evaluates the environmental, financial, and social advantages of transitioning from IR oral morphine solution to IR oro-dispersible morphine tablets within a single National Health Service (NHS) Trust.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A bottom-up CF analysis was conducted on packaging materials. Cost comparisons and surveys of patients and staff evaluated financial and social impacts. Formulations studied were oral morphine solution (Oramorph 10\u00a0mg\/5\u00a0ml) and Oro-dispersible tablets (Actimorph 10\u00a0mg).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>In two sites of a single NHS Trust (inpatients and discharges), switching entirely to tablets could reduce annual carbon dioxide emissions by 7350 kg of carbon dioxide equivalents (53%). Tablets could also eliminate an estimated 275\u2009000 plastic syringes disposed of annually and \u00a316\u2009000 in equipment costs from a 100% switch. A limited patient survey showed that 90% of patients supported the use of environmentally friendly tablets as an alternative to liquid solution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In conclusion, transitioning from oral morphine solutions to tablets has several benefits, including improving environmental sustainability, reducing costs, and enhancing patient care. Collaborative decision-making between healthcare providers and addressing operational challenges are essential for realizing these benefits.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ijpp\/riaf104","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T15:18:16Z","timestamp":1763651896000},"page":"154-161","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the environmental, financial, and social impact of immediate-release morphine tablets compared to oral morphine solution"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-7776","authenticated-orcid":false,"given":"Fatima","family":"Tahir","sequence":"first","affiliation":[{"name":"Department of Oncology, Northern Centre of Cancer Care , Newcastle upon Tyne NE7 7DN ,","place":["United Kingdom"]},{"name":"Centre for Sustainable Healthcare , Oxford OX1 4HL ,","place":["United Kingdom"]},{"name":"Newcastle Hospitals Charity and Sustainability Team, Royal Victoria Infirmary , Newcastle upon Tyne NE1 4LP ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McDonald","sequence":"additional","affiliation":[{"name":"Department of Oncology, Northern Centre of Cancer Care , Newcastle upon Tyne NE7 7DN ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sudan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Northern Centre of Cancer Care , Newcastle upon Tyne NE7 7DN ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Whittaker","sequence":"additional","affiliation":[{"name":"Centre for Sustainable Healthcare , Oxford OX1 4HL ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Cartwright","sequence":"additional","affiliation":[{"name":"Centre for Sustainable Healthcare , Oxford OX1 4HL ,","place":["United Kingdom"]},{"name":"Newcastle Hospitals Charity and Sustainability Team , Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sawyer","sequence":"additional","affiliation":[{"name":"SEE Sustainability , Northallerton DL7 9BW ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Tweddle","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Newcastle Hospitals NHS Foundation Trust , Newcastle upon Tyne NE7 7DN ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Parker","sequence":"additional","affiliation":[{"name":"Newcastle Hospitals Charity and Sustainability Team, Royal Victoria Infirmary , Newcastle upon Tyne NE1 4LP ,","place":["United Kingdom"]},{"name":"Clean Air Fund Partnership RCPCH , London EC3N 1AX ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"2026040801441731600_ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3785","article-title":"A pathway to net zero emissions for healthcare","author":"Salas","year":"2020","journal-title":"BMJ"},{"key":"2026040801441731600_ref2","volume-title":"The Paris Agreement","author":"United Nations Framework Convention on Climate Change (UNFCCC)"},{"key":"2026040801441731600_ref3","volume-title":"Delivering a Net Zero National Health Service","author":"NHS England","year":"2022"},{"key":"2026040801441731600_ref4","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1111\/bcp.16229","article-title":"MCF classifier: estimating, standardising, and stratifying medicine carbon footprints, at scale","volume":"90","author":"Taylor","year":"2024","journal-title":"Br J Clin Pharmacol"},{"key":"2026040801441731600_ref5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.wasman.2023.12.022","article-title":"Life cycle assessment of pharmaceutical packaging addressing end-of-life alternatives","volume":"175","author":"Bassani","year":"2024","journal-title":"Waste Manag"},{"key":"2026040801441731600_ref6","doi-asserted-by":"publisher","first-page":"e076257","DOI":"10.1136\/bmj-2023-076257","article-title":"Why learning how to swallow pills is good for patients, parents, and the planet","volume":"384","author":"Lim","year":"2024","journal-title":"BMJ"},{"key":"2026040801441731600_ref7","doi-asserted-by":"publisher","first-page":"12446","DOI":"10.1007\/s10668-021-01948-2","article-title":"Comparing the environmental impacts of paracetamol dosage forms using life cycle assessment","volume":"24","author":"Sharma","year":"2022","journal-title":"Environ Dev Sustain"},{"key":"2026040801441731600_ref8","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40261-022-01214-x","article-title":"Pharmacokinetics of morphine sulfate orodispersible tablets and bioequivalence with immediate-release oral morphine Sulfate formulations in healthy adult subjects under fasting conditions: single-dose comparative bioavailability studies","volume":"42","author":"Atrux-Tallau","year":"2022","journal-title":"Clin Drug Investig"},{"key":"2026040801441731600_ref9","volume-title":"WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents","author":"World Health Organization","year":"2018"},{"key":"2026040801441731600_ref10","volume-title":"Controlled Drugs and Drug Dependence","author":"National Institute for Health and Care Excellence (NICE)"},{"key":"2026040801441731600_ref11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7861\/futurehosp.5-2-88","article-title":"Sustainability in quality improvement: redefining value","volume":"5","author":"Mortimer","year":"2018","journal-title":"Future Healthc J"},{"key":"2026040801441731600_ref12","volume-title":"Morphine: Medicinal Forms","author":"British National Formulary"},{"key":"2026040801441731600_ref13","doi-asserted-by":"publisher","first-page":"6580","DOI":"10.1021\/acssuschemeng.8b05473","article-title":"Cradle-to-gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations","volume":"7","author":"Parvatker","year":"2019","journal-title":"ACS Sustain Chem Eng"},{"key":"2026040801441731600_ref14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/SLA.0000000000003951","article-title":"The carbon footprint of surgical operations: a systematic review","volume":"272","author":"Rizan","year":"2020","journal-title":"Ann Surg"},{"key":"2026040801441731600_ref15","article-title":"Government of the United Kingdom","year":"2023","journal-title":"Greenhouse Gas Reporting: Conversion Factors"},{"key":"2026040801441731600_ref16","volume-title":"Embodied Carbon Footprint Database","author":"Circular Ecology"},{"key":"2026040801441731600_ref17","volume-title":"Identifying the factors that influence patient acceptability of oral medicines: a systematic review of literature","author":"Payerne","year":"2013"},{"key":"2026040801441731600_ref18","first-page":"78","article-title":"A systematic review of the effects of oral medicine characteristics on patient preference and adherence","volume":"24","author":"Scott","journal-title":"Int J Pharm Pract"},{"key":"2026040801441731600_ref19","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1039\/C7GC00833C","article-title":"Challenges and recommendations for environmental sustainability assessments of pharmaceutical products in the healthcare sector","volume":"19","author":"De Soete","year":"2017","journal-title":"Green Chem"},{"key":"2026040801441731600_ref20","doi-asserted-by":"publisher","first-page":"100298","DOI":"10.1016\/j.joclim.2024.100298","article-title":"The embodied carbon of paracetamol and the consumables associated with different routes of administration in pediatrics","volume":"16","author":"Wilson","year":"2024","journal-title":"J Clim Change Health"},{"key":"2026040801441731600_ref21","volume-title":"North Midlands Controlled Drugs Newsletter","author":"NHS England","year":"2016"},{"key":"2026040801441731600_ref22","volume-title":"Controlled Drugs Newsletter: Sharing Good Practice in the South West","author":"NHS England","year":"2016"},{"key":"2026040801441731600_ref23","volume-title":"CQC\u2019s Controlled Drugs National Group Newsletter","author":"Care Quality Commission","year":"2021"},{"key":"2026040801441731600_ref24","article-title":"Investigation: should liquid morphine Be reclassified?","author":"Wickware","year":"2021","journal-title":"Pharm J"},{"key":"2026040801441731600_ref25","volume-title":"Unintentional Overdose of Morphine Sulfate Oral Solution","author":"Healthcare Safety Investigation Branch (HSIB)"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/34\/2\/154\/65408640\/riaf104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ijpp\/article-pdf\/34\/2\/154\/65408640\/riaf104.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:44:23Z","timestamp":1775627063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/34\/2\/154\/8329279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,20]]},"published-print":{"date-parts":[[2026,4,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ijpp\/riaf104","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,20]]}}}